We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Exploring the micro- and nanoplastics–diabetes nexus: Shattered barriers, toxic links, and methodological horizons
AI summary Read the abstract
This review examines growing evidence that micro- and nanoplastics may contribute to diabetes by disrupting blood sugar regulation, insulin signaling, and fat metabolism through oxidative stress and inflammation. Animal studies show that plastic particles can damage the pancreas, liver, and gut in ways that mirror the development of diabetes, though human studies are still limited. The review calls for more research into whether everyday microplastic exposure could be a hidden factor in the global rise of metabolic diseases.
Micro- and nanoplastics (MNPs) are emerging environmental contaminants with increasing evidence linking them to metabolic dysfunction, including diabetes-related outcomes. While experimental studies have demonstrated that MNPs disrupt glucose metabolism, insulin signaling, and lipid homeostasis through oxidative stress, systemic inflammation, and endocrine disruption, the implications for human health remain largely unexplored. Given the widespread presence of MNPs in food, water, and air, chronic low-dose exposure may contribute to metabolic disorders, yet epidemiological data are scarce. This review synthesizes current findings on MNP-induced metabolic disturbances, highlighting their impact on insulin resistance, hepatic fat accumulation, gut microbiota dysbiosis, and adipose tissue dysfunction. Additionally, we evaluate the analytical methodologies used to detect MNPs in biological systems and assess the relevance of exposure levels in real-world scenarios. By contextualizing these mechanisms within a broader public health framework, this review underscores the urgent need for large-scale human studies to establish causal links between MNP exposure and metabolic diseases. Addressing these knowledge gaps is critical for informing risk assessment, regulatory policies, and future research directions aimed at mitigating the metabolic risks associated with environmental plastic pollution.
More Papers Like This
New Insights into the Relationship Between Microplastics and Diabetes from the Perspective of the Gut–Liver Axis and Macrophage Regulation
AI summary Read the abstract
This review paper summarizes research suggesting that tiny plastic particles (microplastics) we're exposed to from the environment might increase the risk of developing type 2 diabetes. The studies show microplastics could damage the gut, trigger inflammation, and disrupt how the body processes sugar, though this evidence comes mainly from animal studies rather than human research. While more human studies are needed to confirm these effects, the findings suggest reducing plastic pollution could be important for preventing diabetes and other metabolic diseases.
Biological exposure to microplastics and nanoplastics and plastic additives: impairment of glycolipid metabolism and adverse effects on metabolic diseases
AI summary Read the abstract
This review examines how exposure to micro- and nanoplastics disrupts the body's ability to process sugars and fats, potentially contributing to diabetes, obesity, and atherosclerosis. The plastics cause inflammation and oxidative stress, damage gut bacteria, trigger insulin resistance, and increase fat buildup in the liver. For people who already have metabolic conditions, plastic exposure may make their disease worse.
Microplastics and Nanoplastics as Potential Metabolic Disruptors: Implications for Insulin Resistance and Type 2 Diabetes
AI summary Read the abstract
Tiny plastic particles have been found throughout our bodies—in blood, lung tissue, even the placenta—and this review explores early evidence that they might disrupt gut health and metabolism in ways that could contribute to insulin resistance and type 2 diabetes. The theory: these particles may damage the gut lining, throw off gut bacteria and digestive hormones, and trigger low-level inflammation in the liver. It's important to note this is still a hypothesis based mostly on animal studies, not proof that microplastics cause diabetes in humans, but it highlights a research area worth watching closely.
Metabolic footprint of microplastics and nanoplastics: From environmental exposure to metabolic diseases
AI summary Read the abstract
Tiny plastic particles that get into our bodies through food, water, and air may be quietly messing with how our cells produce energy, process fat, and respond to insulin—potentially raising the risk of obesity, type 2 diabetes, and fatty liver disease. This review pulls together existing research to explain how these particles disrupt gut bacteria and cell function, with smaller plastic pieces generally causing more harm. While more research is needed to confirm long-term effects in humans, the findings suggest reducing plastic exposure where possible may be a smart precaution for metabolic health.
Emerging Contaminants: An Emerging Risk Factor for Diabetes Mellitus
AI summary Read the abstract
This review examines how emerging environmental contaminants, including microplastics and nanoplastics, may contribute to the development and progression of diabetes. These contaminants can disrupt glucose metabolism through oxidative stress, inflammation, and interference with hormone signaling. The findings suggest that chronic exposure to microplastics and other pollutants in food and water could be an overlooked risk factor for the growing global diabetes epidemic.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.